FK UISU
2010
Pendahuluan
retensi
air
resistensi
pblh darah
perifer
kadar
aldosteron
Perubahan
selama kehamilan
Pe
Progresif
renin pd
kehamilan
cardiac
output
tekanan
osmotik
koloid
CO2 gradien
antara ibu & janin
pengosongan
lambung
lemak
tubuh
Aliran darah ginjal
& GFR awal
kehamilan &
akhir kehamilan
absorpsi
Perubahan
selama kehamilan
intestinal
transit times
>> penyimpanan
lemak dan
glikogen pd hepar
Perubahan
selama kehamilan
1.
2.
3.
Durasi paparan
4.
5.
6.
1. Sifat Fisikokimiawi
obat
B. Ikatan protein
C. Ukuran molekul
D. Metabolisme obat pada plasenta & janin
E. Transport plasenta
2. Derajat ionisasi
B. Ikatan protein
C. Ukuran molekul
2.
E. Transport plasenta
1.
2.
3.
4.
5.
Cth : thalidomide
Mekanisme teratogenik
ACE Inhibitors
Aminopterin
Amphetamines
Androgens
TCAs
BARBs
Busulfan
Carbamazepine
Chlorpropamide
Clomipramine
Cocaine
Cyclophosphami
de
Cytarabine
Diazepam
DES
Ethanol
Etretinate
Heroin
Iodide
Isotretinoin
Lithium
Methadone
Methotrexate
Methylthiouracil
Metronidazole
Organic solvents
Misoprostol
Penicillamine
Phencyclidine
Phenytoin
Propylthiouracil
Streptoycin
Tamoxifen
Tetracycline
Thalidomide
Trimethadione
Valproic acid
Warfarin
Category A.
Controlled Studies have not demonstrated fetal risk
Category B.
Studies in animals have not demonstrated fetal risk
Category C.
Studies in women or animals are not available
Category D.
There is positive evidence of human risk. However,
the benefits of use in pregnancy may be acceptable
in spite of this risk
Category X.
Studies or experience in humans or animals
has demonstrated fetal risk. The risk far outweighs any
potential benefit. The drug is contraindicated
in pregnant women or women who may become
pregnant
Kesimpulan